356 related articles for article (PubMed ID: 12105240)
41. The in situ expression of interleukin-8 in the normal human kidney and in different morphological forms of glomerulonephritis.
Niemir ZI; Stein H; Ciechanowicz A; Olejniczak P; Dworacki G; Ritz E; Waldherr R; Czekalski S
Am J Kidney Dis; 2004 Jun; 43(6):983-98. PubMed ID: 15168378
[TBL] [Abstract][Full Text] [Related]
42. Expression of macrophage migration inhibitory factor in human glomerulonephritis.
Lan HY; Yang N; Nikolic-Paterson DJ; Yu XQ; Mu W; Isbel NM; Metz CN; Bucala R; Atkins RC
Kidney Int; 2000 Feb; 57(2):499-509. PubMed ID: 10652026
[TBL] [Abstract][Full Text] [Related]
43. Jak3 expression in glomerular epithelia of IgA nephropathy (IgA-N) patients.
Takahashi T; Shirasawa T; Miyake K; Yahagi Y; Matsumura O; Abe A; Natori Y; Yamabe H; Utsunomiya Y; Maruyama N; Mitarai T; Sakai O
Clin Exp Immunol; 1996 Jun; 104(3):517-24. PubMed ID: 9099938
[TBL] [Abstract][Full Text] [Related]
44. Expression of Fas antigen and Bcl-2 in human glomerulonephritis.
Takemura T; Murakami K; Miyazato H; Yagi K; Yoshioka K
Kidney Int; 1995 Dec; 48(6):1886-92. PubMed ID: 8587248
[TBL] [Abstract][Full Text] [Related]
45. The cyclin-dependent kinase inhibitor p21 limits murine mesangial proliferative glomerulonephritis.
Monkawa T; Pippin J; Yo Y; Kopp JB; Alpers CE; Shankland SJ
Nephron Exp Nephrol; 2006; 102(1):e8-18. PubMed ID: 16179805
[TBL] [Abstract][Full Text] [Related]
46. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM.
Del Prete D; Anglani F; Forino M; Ceol M; Fioretto P; Nosadini R; Baggio B; Gambaro G
Diabetologia; 1997 Dec; 40(12):1449-54. PubMed ID: 9447953
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
Steinmann-Niggli K; Ziswiler R; Küng M; Marti HP
J Am Soc Nephrol; 1998 Mar; 9(3):397-407. PubMed ID: 9513901
[TBL] [Abstract][Full Text] [Related]
48. [Clinical pathology of the glomerulus--from phenomenon to entity. The extracapillary lesion].
Rumpelt HJ
Verh Dtsch Ges Pathol; 1989; 73():83-93. PubMed ID: 2482638
[TBL] [Abstract][Full Text] [Related]
49. Nephronectin expression in glomeruli of renal biopsy specimens from various kidney diseases: nephronectin is expressed in the mesangial matrix expansion of diabetic nephropathy.
Nakatani S; Ishimura E; Mori K; Fukumoto S; Yamano S; Wei M; Emoto M; Wanibuchi H; Inaba M
Nephron Clin Pract; 2012; 122(3-4):114-21. PubMed ID: 23689482
[TBL] [Abstract][Full Text] [Related]
50. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
[TBL] [Abstract][Full Text] [Related]
51. Alpha8 integrin in glomerular mesangial cells and in experimental glomerulonephritis.
Hartner A; Schöcklmann H; Pröls F; Müller U; Sterzel RB
Kidney Int; 1999 Oct; 56(4):1468-80. PubMed ID: 10504498
[TBL] [Abstract][Full Text] [Related]
52. [Clinical implications of DNA-topoisomerases examination in renal biopsies from patients with nephritis].
Ivanova LV; Shilov EM; Ivanov AA; Kozlovskaia LV; Rudolph P; Proppe D
Ter Arkh; 2003; 75(6):11-7. PubMed ID: 12920952
[TBL] [Abstract][Full Text] [Related]
53. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
Hedberg A; Fismen S; Fenton KA; Mortensen ES; Rekvig OP
Exp Dermatol; 2010 Aug; 19(8):e265-74. PubMed ID: 20500770
[TBL] [Abstract][Full Text] [Related]
54. Tissue culture of isolated glomeruli from patients with glomerulonephritis.
Atkins RC; Glasgow EF; Holdsworth SR; Thomson NM; Hancock WW
Kidney Int; 1980 Apr; 17(4):515-27. PubMed ID: 7392425
[TBL] [Abstract][Full Text] [Related]
55. Glomerular enlargement in the progression of mesangial proliferative glomerulonephritis.
Daimon S; Koni I
Clin Nephrol; 1998 Mar; 49(3):145-52. PubMed ID: 9543595
[TBL] [Abstract][Full Text] [Related]
56. Glomerular plasmin-like activity in relation to nephritis-associated plasmin receptor in acute poststreptococcal glomerulonephritis.
Oda T; Yamakami K; Omasu F; Suzuki S; Miura S; Sugisaki T; Yoshizawa N
J Am Soc Nephrol; 2005 Jan; 16(1):247-54. PubMed ID: 15574512
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase-2, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in the peripheral blood of patients with various glomerular diseases and their implication in pathogenetic lesions: study based on an enzyme-linked assay and immunohistochemical staining.
Endo T; Nakabayashi K; Sekiuchi M; Kuroda T; Soejima A; Yamada A
Clin Exp Nephrol; 2006 Dec; 10(4):253-61. PubMed ID: 17186329
[TBL] [Abstract][Full Text] [Related]
58. Cross-reactivity of eluted antibodies from renal tissues of patients with henoch-Schönlein purpura nephritis and IgA nephropathy.
Tomino Y; Sakai H; Endoh M; Miura M; Suga T; Kaneshige H; Nomoto Y
Am J Nephrol; 1983; 3(6):315-8. PubMed ID: 6650587
[TBL] [Abstract][Full Text] [Related]
59. Proliferative glomerulonephritis in rats: evidence that mononuclear phagocytes infiltrating the glomeruli stimulate the proliferation of endothelial and mesangial cells.
Dubois CH; Foidart JB; Hautier MB; Dechenne CA; Lemaire MJ; Mahieu PR
Eur J Clin Invest; 1981 Apr; 11(2 Suppl 1):91-104. PubMed ID: 6785101
[TBL] [Abstract][Full Text] [Related]
60. A novel evaluation method for paraffinized human renal biopsies using quantitative analysis of microdissected glomeruli and VCAM-1 as marker of inflammatory mesangial cell activation.
Fries JW; Roth T; Dienes HP; Weber M; Odenthal M
Nephrol Dial Transplant; 2003 Apr; 18(4):710-6. PubMed ID: 12637639
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
